Expert Panel Tells IPCA to Revise Hydroxychloroquine Phase III Trial for Diabetes Dr. Divya Colin28 May 2025 11:35 PM ISTNew Delhi: In response to the proposal presented by IPCA Laboratories Limited, the Subject Expert Committee (SEC) functional under the Central Drug...
Olezarsen Significantly Reduces Triglycerides in Moderate hypertriglyceridemia Patients at ASCVD Risk: Essence study Dr. Kamal Kant Kohli21 May 2025 9:00 AM ISTTopline results from the Essence study show that olezarsen significantly lowered mean triglyceride levels compared to placebo in individuals with...
Calprotectin Shows Promise as Independent Biomarker for ASCVD: JAMA Dr Riya Dave9 May 2025 8:45 AM ISTAccording to a new study published in JAMA ,calprotectin may serve as a mechanistically informed biomarker for atherosclerotic cardiovascular disease...
DASH Diet and Sodium may together or independently Reduce ASCVD Risk among adults with high BP: Study Jacinthlyn Sylvia3 May 2025 9:30 AM ISTA new study published in the American Journal of Preventive Cardiology showed that the Dietary Approaches to Stop Hypertension (DASH) diet and salt...
Anemia May Heighten Cardiovascular Risk in Hypertensive Patients, Warn Researchers Medha Baranwal23 April 2025 8:00 AM ISTChina: A new study highlights the critical role of anemia in influencing cardiovascular risk in individuals with hypertension (HTN), particularly...
Minimal TV viewing protective for heart diseases linked to Type 2 diabetes: Study Dr. Kamal Kant Kohli24 March 2025 8:45 AM IST Watching no more than one hour of TV a day may lower the risk of heart attack, stroke and other blood vessel diseases among people with varying...
New AACE 2025 Dyslipidemia Management Guidelines Released – Top 7 Takeaways Nidhi Srivastava19 Feb 2025 2:52 PM ISTOhio: The 2025 American Association of Clinical Endocrinology (AACE) guidelines offer evidence-based recommendations for the pharmacologic management...
Lipoprotein(a), ASCVD risk, and Aspirin- What is the Latest Evidence Saying? Dr. Roopali Khanna7 Feb 2025 12:21 PM ISTLipoprotein (a) [Lp(a)] is considered pro-atherosclerotic, pro-inflammatory, pro-thrombotic, and anti-fibrinolytic. Lipoprotein(a) levels >50 mg/dL...
Global HIV study finds cardiovascular risk models underestimate for key populations Dr. Kamal Kant Kohli24 Jan 2025 9:00 PM ISTCardiovascular disease (CVD) is the leading cause of morbidity and mortality globally, posing a particularly significant threat to people with HIV...
Alternative LDL Cholesterol safely and effectively lowers risk of ASCVD instead of high intensity statins: JAMA Dr.Niharika Harsha B26 Nov 2024 9:00 AM ISTAn alternative low-density lipoprotein (LDL) cholesterol-lowering strategy can successfully reduce the risk of atherosclerotic cardiovascular...
Impact of Regular Aspirin Use on ASCVD Mortality in Adults with Elevated Lipoprotein(a) Levels Prof. Soumitra Kumar1 Oct 2024 12:52 PM ISTWith a rising incidence of cardiovascular disease (CVD) among younger individuals aged below 55 years(1),particularly in India, where it occurs about...
Single measures of non HDL-C and LDL-C between ages 18 and 30 years may predic CAD, finds study Medha Baranwal11 Sept 2024 9:00 AM ISTUSA: Single measurements of non-HDL cholesterol (non-HDL-C) and LDL cholesterol (LDL-C) taken between 18 and 30 years of age are strong indicators of...
